Microbix Biosystems Inc.
MBX.TO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$42.63M
Close$
$0.06
78.9% downside
Current Fair Value
78.9% downsideOvervalued by 78.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $42.63 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.02 |
| Beta | 0.54 |
| Outstanding Shares | 134,460,333 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -8.78 |
|---|---|
| PEG | 17.26 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$5.20 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 17, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$4.40 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Microbix Biosystems Inc.
100 employees
CEO: Cameron L. Groome
Microbix Biosystems Inc. is a life sciences enterprise that invents and markets unique biological and technological innovations designed to improve human health and well-being. Operating across North America, Europe, and other internatio...